The Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs)
Hosted by the Rwandan Government, the Kigali Summit gathered governments, pharmaceutical companies, donors,...
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead’s vision is to create a healthier world for all people and we pursue initiatives that help improve global health equity. It is our joint responsibility to create ways in which access to care and treatment can be achieved globally in partnership with governments, civil society and communities we serve.
Since 1987, Gilead has commercialized more than 25 innovative medicines, helping to transform treatment for people living with diseases such as HIV, viral hepatitis, COVID-19, neglected tropical diseases and cryptococcal meningitis around the world. More importantly, we aim for our contribution to go beyond medicines: our goal is to eliminate diseases and deliver meaningful impact backed up by rigorous assessment.
SHOWING 5 of 11 COLLABORATIONS
See AllHosted by the Rwandan Government, the Kigali Summit gathered governments, pharmaceutical companies, donors,...
Signing the Kigali Declaration on NTDs, governments, pharmaceutical companies, donors, and NGOs renewed and...
Global coalition to increase access to essential cancer medicines in low- and lower middle-income countries....
Pat-INFORMED, a private-public partnership between the World Intellectual Property Organisation, the...
Gilead is supporting the Spouses of CARICOM Leaders Action Network (SCLAN) to expand access to HIV prevention...
SHOWING 5 of 11 COLLABORATIONS
See All